Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Targeted Therapies introduces Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
Browse by Series:
Case 2: CPX-351 Trial Data in AML
Case 2: CPX-351 Trial Data in AML
Case 2: Selecting a Targeted Therapy for AML With MRC
Case 2: Selecting a Targeted Therapy for AML With MRC
Case 2: CPX-351 Treatment for AML With MRC
Case 2: CPX-351 Treatment for AML With MRC
Case 2: AML With Myelodysplasia-Related Changes
Case 2: AML With Myelodysplasia-Related Changes
Case 3: Chemoimmunotherapy in SCLC
Case 3: Chemoimmunotherapy in SCLC
Case 3: Pathology Considerations in SCLC
Case 3: Pathology Considerations in SCLC
Case 3: Extensive-Stage SCLC
Case 3: Extensive-Stage SCLC
Case 2: Osimertinib in EGFR-Mutated Lung Cancer
Case 2: Osimertinib in EGFR-Mutated Lung Cancer
Case 2: Frontline Therapy in EGFR-Mutated Lung Cancer
Case 2: Frontline Therapy in EGFR-Mutated Lung Cancer
Case 2: Testing for EGFR in Lung Adenocarcinoma
Case 2: Testing for EGFR in Lung Adenocarcinoma
Case 2: Diagnosing PD-L1+ and EGFR+ Lung Adenocarcinoma
Case 2: Diagnosing PD-L1+ and EGFR+ Lung Adenocarcinoma
Case 2: PD-L1+ and EGFR+ Lung Adenocarcinoma
Case 2: PD-L1+ and EGFR+ Lung Adenocarcinoma
<< Prev Page
Next Page >>
Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.